메뉴 건너뛰기




Volumn 17, Issue 3, 2012, Pages 356-360

Posterior reversible encephalopathy syndrome as the initial manifestation of Guillain-Barré syndrome: Case report and review of the literature

Author keywords

dyasutonomia; Guillain Barr ; posterior reversible encephalopathy

Indexed keywords

ANTINUCLEAR ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; IMMUNOGLOBULIN; LABETALOL;

EID: 84866399290     PISSN: 10859489     EISSN: 15298027     Source Type: Journal    
DOI: 10.1111/j.1529-8027.2012.00416.x     Document Type: Article
Times cited : (29)

References (14)
  • 1
    • 79952176151 scopus 로고    scopus 로고
    • Posterior reversible encephalopathy syndrome resulting from Guillain Barré-like syndrome secondary to West Nile virus infection
    • Abraham A, Ziv S, Drory VE, (2011). Posterior reversible encephalopathy syndrome resulting from Guillain Barré-like syndrome secondary to West Nile virus infection. J Clin Neuromuscul Dis 12: 113-117.
    • (2011) J Clin Neuromuscul Dis , vol.12 , pp. 113-117
    • Abraham, A.1    Ziv, S.2    Drory, V.E.3
  • 2
    • 77952546636 scopus 로고    scopus 로고
    • Posterior reversible encephalopathy syndrome as a complication of Guillain-Barré syndrome
    • Bavikatte G, Gaber T, Eshiett MU, (2010). Posterior reversible encephalopathy syndrome as a complication of Guillain-Barré syndrome. J Clin Neurosci 17: 924-926.
    • (2010) J Clin Neurosci , vol.17 , pp. 924-926
    • Bavikatte, G.1    Gaber, T.2    Eshiett, M.U.3
  • 4
    • 24644449148 scopus 로고    scopus 로고
    • Posterior reversible encephalopathy syndrome as the initial manifestation of Guillain-Barré syndrome
    • Elahi A, Kelkar P, St Louis EK, (2004). Posterior reversible encephalopathy syndrome as the initial manifestation of Guillain-Barré syndrome. Neurocrit Care 1: 465-468.
    • (2004) Neurocrit Care , vol.1 , pp. 465-468
    • Elahi, A.1    Kelkar, P.2    St Louis, E.K.3
  • 5
    • 84859100520 scopus 로고    scopus 로고
    • Posterior reversible encephalopathy syndrome as a revealing manifestation of Guillain-Barré syndrome
    • Exteberria A, Lonneville S, Rutgers MP, Gille MP, (2012). Posterior reversible encephalopathy syndrome as a revealing manifestation of Guillain-Barré syndrome. Rev Neurol (Paris) 168: 283-286.
    • (2012) Rev Neurol (Paris) , vol.168 , pp. 283-286
    • Exteberria, A.1    Lonneville, S.2    Rutgers, M.P.3    Gille, M.P.4
  • 7
    • 84855954574 scopus 로고    scopus 로고
    • Autoimmune disorders affecting both the central and peripheral nervous system
    • Kamm C, Zettl UK, (2012). Autoimmune disorders affecting both the central and peripheral nervous system. Autoimmun Rev 11: 196-202.
    • (2012) Autoimmun Rev , vol.11 , pp. 196-202
    • Kamm, C.1    Zettl, U.K.2
  • 9
    • 1642268710 scopus 로고    scopus 로고
    • Neuroimaging in posterior reversible encephalopathy syndrome
    • Lamy C, Oppenheim C, Meder JF, Mas JL, (2004). Neuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging 14: 89-96.
    • (2004) J Neuroimaging , vol.14 , pp. 89-96
    • Lamy, C.1    Oppenheim, C.2    Meder, J.F.3    Mas, J.L.4
  • 10
    • 0027125622 scopus 로고
    • The Guillain-Barré syndrome
    • Ropper AH, (1992). The Guillain-Barré syndrome. N Engl J Med 326: 1130-1136.
    • (1992) N Engl J Med , vol.326 , pp. 1130-1136
    • Ropper, A.H.1
  • 12
    • 70349249337 scopus 로고    scopus 로고
    • Posterior reversible encephalopathy syndrome as the initial manifestation of a Guillain-Barré syndrome
    • Sutter R, Mengiardi B, Lyrer P, Czaplinski A, (2009). Posterior reversible encephalopathy syndrome as the initial manifestation of a Guillain-Barré syndrome. Neuromuscul Dis 19: 709-710.
    • (2009) Neuromuscul Dis , vol.19 , pp. 709-710
    • Sutter, R.1    Mengiardi, B.2    Lyrer, P.3    Czaplinski, A.4
  • 14
    • 51449103646 scopus 로고    scopus 로고
    • Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome
    • van Doorn PA, Ruts L, Jacobs BC, (2008). Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol 7: 939-950.
    • (2008) Lancet Neurol , vol.7 , pp. 939-950
    • Van Doorn, P.A.1    Ruts, L.2    Jacobs, B.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.